Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverly L Davidson

Showing results (51-60 of 205) with videos related to

Pageof 21
Sort By:
FEBS Letters|April 23, 2003
Membrane topology of CLN3, the protein underlying Batten diseaseQinwen Mao, Brian J Foster, Haibin Xia, et al.
Nature Biotechnology|September 24, 2002
siRNA-mediated gene silencing in vitro and in vivoHaibin Xia, Qinwen Mao, Henry L Paulson, et al.
Journal of Medicinal Chemistry|April 18, 2003
Tripeptide probes for tripeptidyl protease I production via gene transferMeeKyoung Kim, Qinwen Mao, Beverly L Davidson, et al.
Trends in Neurosciences|July 5, 2011
Clarifying lysosomal storage diseasesMark L Schultz, Luis Tecedor, Michael Chang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2022
Limited astrocyte-to-neuron conversion in the mouse brain using NeuroD1 overexpressionDavid Leib, Yong Hong Chen, Alex Mas Monteys, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 8, 2023
Targeted long-read sequencing captures CRISPR editing and AAV integration outcomes in brainBryan P Simpson, Carolyn M Yrigollen, Aleksandar Izda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2012
Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage diseaseYong Hong Chen, Kristin Claflin, James C Geoghegan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 11, 2005
Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystoniaPedro Gonzalez-Alegre, Nicole Bode, Beverly L Davidson, et al.
Plos One|June 16, 2012
MiR-34a represses Numbl in murine neural progenitor cells and antagonizes neuronal differentiationSarah K Fineberg, Poppy Datta, Colleen S Stein, et al.
Neurobiology of Disease|September 30, 2010
A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structuresSong-Lin Ding, Luis Tecedor, Colleen S Stein, et al.
Pageof 21

Showing results (51-60 of 205) with videos related to

Sort By:
Pageof 21
FEBS Letters|April 23, 2003
Membrane topology of CLN3, the protein underlying Batten diseaseQinwen Mao, Brian J Foster, Haibin Xia, et al.
Nature Biotechnology|September 24, 2002
siRNA-mediated gene silencing in vitro and in vivoHaibin Xia, Qinwen Mao, Henry L Paulson, et al.
Journal of Medicinal Chemistry|April 18, 2003
Tripeptide probes for tripeptidyl protease I production via gene transferMeeKyoung Kim, Qinwen Mao, Beverly L Davidson, et al.
Trends in Neurosciences|July 5, 2011
Clarifying lysosomal storage diseasesMark L Schultz, Luis Tecedor, Michael Chang, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2022
Limited astrocyte-to-neuron conversion in the mouse brain using NeuroD1 overexpressionDavid Leib, Yong Hong Chen, Alex Mas Monteys, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 8, 2023
Targeted long-read sequencing captures CRISPR editing and AAV integration outcomes in brainBryan P Simpson, Carolyn M Yrigollen, Aleksandar Izda, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 17, 2012
Sialic acid deposition impairs the utility of AAV9, but not peptide-modified AAVs for brain gene therapy in a mouse model of lysosomal storage diseaseYong Hong Chen, Kristin Claflin, James C Geoghegan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 11, 2005
Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystoniaPedro Gonzalez-Alegre, Nicole Bode, Beverly L Davidson, et al.
Plos One|June 16, 2012
MiR-34a represses Numbl in murine neural progenitor cells and antagonizes neuronal differentiationSarah K Fineberg, Poppy Datta, Colleen S Stein, et al.
Neurobiology of Disease|September 30, 2010
A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structuresSong-Lin Ding, Luis Tecedor, Colleen S Stein, et al.
Pageof 21